Medication reference
Regular insulin
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Insulin (regular) (opens in a new tab)Original source URL: https://globalrph.com/dilution/insulin-regular/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/insulin-regular/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:49:26.880780+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- a2b5b069680ea4ba8cef5a2ccc0bf3ce90f3ebfa062ec5ac9414a73f6afa3579
- Original response SHA-256
- d99491a293b06fa2b5db28aadcea3fad2a48bd655ee091fc4d64944f26ee32eb
- Source body SHA-256
- 80437df13202ff632558c7e6a0b257696ccf90431e3edb643b096230a216506d
Insulin (regular) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| NS |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| Usual final concentrations: 0.5 unit/ml or 1 unit/ml (ICU's only - Detroit VAMC) |
Stability / Miscellaneous |
| EXP: 1 DAY (RT/REF) |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- monitor_or_titrate
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- regular-insulin
Source ID
H51-90A97AEDD80AF98A0A6ED6CE - Generic name
- Regular insulin
Source ID
H51-DF4F0CACF316F9700DE7CEAB - Class
- Endocrine and metabolic
Source ID
H51-FDC87B51CA7EEDD613C36F92 - Subclass
- Short-acting insulin
Source ID
H51-A630F15112EAF7EF14B4A656 - Primary uses
- Diabetic ketoacidosis
Source ID
H51-07D10EB6108309113410599B - Hyperglycemia in critical illness
Source ID
H51-4A913D16229C57EBDF1FE3BA - Hyperkalemia as part of a treatment bundle
Source ID
H51-B2E943B4070D5AA083FFAA23
- Diabetic ketoacidosis
- Mechanism
- Activates insulin receptor tyrosine kinase, promotes glucose uptake, suppresses hepatic glucose output, and shifts potassium into cells.
Source ID
H51-A754E15EAA24FF56F6AA569F - Mechanism level
- drug_specific
Source ID
H51-38EB1DFFD6A14A60E70FEB9F - Basic dosing orientation
- Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 100 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion
Source ID
H51-A41BA7345B1DFBDCA3CECE4D - Administration orientation
- Titrate by units/hour or units/kg/hour according to protocol; Titrate by units/kg/hour; 100 units/mL stock may require careful measurement; use standardized syringe; IV bolus per hyperkalemia protocol
Source ID
H51-49A33171559FDA755405B50F - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
Source ID
H51-32172B699DD63A267988E8E8 - Key safety orientation
- Hypoglycemia and hypokalemia.
Source ID
H51-8FF16E0D7F4459BFFA948010 - Tenfold concentration errors can be fatal.
Source ID
H51-41C6376ED41AC383F5884361 - Only regular insulin is routinely used IV unless a specific product/protocol says otherwise.
Source ID
H51-A21934504DE408F785BE5E22
- Hypoglycemia and hypokalemia.
- Coverage path
- structured_local_snapshot
Source ID
H51-06C4DDBAF45DDAA500D537CD - Coverage path label
- Structured GlobalRPh route snapshot
Source ID
H51-1DC669C50CABC7CFC4E61674 - Legacy title
- Regular insulin
Source ID
H51-19C995EC70FD0B010384281E - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-BEB63915E2B2AF98140C1667 - Search text
- Regular insulin Endocrine and metabolic Short-acting insulin Diabetic ketoacidosis Hyperglycemia in critical illness Hyperkalemia as part of a treatment bundle Activates insulin receptor tyrosine kinase, promotes glucose uptake, suppresses hepatic glucose output, and shifts potassium into cells. Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Common bag 100 units | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Pediatric infusion | Existing preparation record; use current package insert for indication-specific selection | Weight-based protocol | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion Titrate by units/hour or units/kg/hour according to protocol; Titrate by units/kg/hour; 100 units/mL stock may require careful measurement; use standardized syringe; IV bolus per hyperkalemia protocol Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply. Hypoglycemia and hypokalemia. Tenfold concentration errors can be fatal. Only regular insulin is routinely used IV unless a specific product/protocol says otherwise. Structured GlobalRPh route snapshot
Source ID
H51-49D559980EBE24404E1377FF - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Regular+insulin (opens in a new tab)
Source ID
H51-E30C7D67980B93BEE59B0115 - Official access mode
- search
Source ID
H51-0ABC8EF048E33A3CBE6D6249 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Regular+insulin (opens in a new tab)
Source ID
H51-B6E2F46A049D87946616E026 - Official search query
- Regular insulin
Source ID
H51-F673A314EAD15F87C53850FD - Official access reason
- A source-backed DailyMed search is available; select and confirm the exact IV product.
Source ID
H51-081289169F76DEF84A01A630
No separate structured rows were bundled for dialysis, CRRT. Historical article content and source links may cover these topics.
Historical dilution and intermittent infusion preparation
Recovered v5.1 source content; historical, awaiting current review.
| Population | Amount | Reconstitution | Diluent | Final volume | Concentration | Rate | Stability | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-F3E273BB0E48CB9293CC964ESource IDH51-0FACCA26B5682EF73B51EADB | Common bag 100 unitsSource IDH51-F5B9D40DE739C83F51EFF9A9 | Add regular insulin to compatible bag using independent double check.Source IDH51-6F3034A456C019A90756B1F3 | NSSource IDH51-73AFAD5788BB6FB0816BC64A | 100 mLSource IDH51-C883F472086513D392200348 | 1 unit/mLSource IDH51-6989D752FF76B94BFC8C01F6 | Titrate by units/hour or units/kg/hour according to protocolSource IDH51-ED6A4C5A5D1810FBD56C23FF | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-4554F8C3A754A513C7E46E68 | Prime tubing with insulin solution per local policy to reduce adsorption.Source IDH51-20F6FC44E8240376BBD806AF |
Source IDH51-BC5D4A057D15BB5EA4CBE48ASource IDH51-5663BD58F110BCF31448BDDD | Weight-based protocolSource IDH51-17CCF9817ABDA92DA81B30FB | Pharmacy-prepared standardized concentration.Source IDH51-85E7F2146DC27384E6B2879C | NSSource IDH51-4CA579D6890B64B8C91F07BD | Weight-appropriate volumeSource IDH51-09C1E838D979939151499ECF | Commonly 0.1 or 1 unit/mL depending on age and deviceSource IDH51-207FC6CB56FD30FC85D93592 | Titrate by units/kg/hourSource IDH51-61B796B4593244BCEE0DED4F | Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.Source IDH51-B29D1C31531B8426C8DE7288 |
Historical IV-push guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Dose scope | Concentration | Rate | Status | Notes |
|---|---|---|---|---|---|
Source IDH51-17D811A90BC1A4955934B22CSource IDH51-F0ECAD09B30F4BC050DCC07D | Commonly 5 to 10 units regular insulin with dextrose per protocolSource IDH51-F6924C5E5086406522933F3F | 100 units/mL stock may require careful measurement; use standardized syringeSource IDH51-D47F1D0B8829FFB65C0EE92F | IV bolus per hyperkalemia protocolSource IDH51-5958F7254FDE3ED7C88CE135 | High-alert protocol onlySource IDH51-CDE724012C78EA86704D3FA4 | Hypoglycemia can occur several hours later; dextrose and monitoring plan are mandatory.Source IDH51-0C9AA4501F9ADBAAC2E1CBB7 |
Historical continuous-infusion guidance
Recovered v5.1 source content; historical, awaiting current review.
| Population | Standard concentration | Initial rate | Titration | Maximum | Notes |
|---|---|---|---|---|---|
Source IDH51-2728AAA8F1212E0424D241BBSource IDH51-4652432F6C874C4D5D399B75 | 100 units/100 mL NS (1 unit/mL)Source IDH51-C4A5E8E735CC53F8809CDD5D | Indication-specific; DKA often 0.1 unit/kg/hour or protocol alternativeSource IDH51-24DA306C3FC1329449F23E7F | Titrate to glucose, ketone, and anion-gap goalsSource IDH51-3411EC538DF25A44D1D4B904 | Protocol-specificSource IDH51-EAB99F7A6AC9540D8319BED5 | Use a dedicated line and standardized glucose/potassium monitoring.Source IDH51-8BBF9351223C3FEB04B3ADB3 |
Historical indication and population dosing
Recovered tables and source-separated snapshots; full clinical revalidation remains pending.
Existing dose and route snapshots
| Route | Population | Indication | Dose | Interval | Duration | Administration | Source level | Notes |
|---|---|---|---|---|---|---|---|---|
Source IDH51-7362A06452A1F8245FFD52EASource IDH51-7289AAFE716ADC06B35A1812 | Adult infusionSource IDH51-A98183C6A0CD5CDC5F29C97E | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-EAC690941F373CCCEA744AFC | Common bag 100 unitsSource IDH51-8369F0831362D17396CBF38A | Not normalized in the preparation recordSource IDH51-421FCF7C5D706126CEF6FBB9 | See current package insert and professional guidanceSource IDH51-D50F2BBC4442FDBA914AB5AA | Titrate by units/hour or units/kg/hour according to protocolSource IDH51-D5AA4A7231CF86F174DCE77C | Existing GlobalRPh structured preparation snapshotSource IDH51-C84B3602ED0696918B1A19D7 | Prime tubing with insulin solution per local policy to reduce adsorption.Source IDH51-1AFAA3101DB42E4BF1CC7F80 |
Source IDH51-2CC4B8D6BB6CDCDA4BEECA2ASource IDH51-805626FBAE368D50E445D236 | Pediatric infusionSource IDH51-063F0301FF7AF28FC9B4B121 | Existing preparation record; use current package insert for indication-specific selectionSource IDH51-F781A823A182AA128B2FC225 | Weight-based protocolSource IDH51-D2A9EA5A8A3D25AB42D24C04 | Not normalized in the preparation recordSource IDH51-7DA55DFD6626EE1F05935987 | See current package insert and professional guidanceSource IDH51-165535F13B067E8C7D853B46 | Titrate by units/kg/hourSource IDH51-09A56030125531A303972FDC | Existing GlobalRPh structured preparation snapshotSource IDH51-2BB273A7ECBD15CD7DFCA2F8 | |
Source IDH51-3CA35283BAF521CFEC7309AESource IDH51-F0A02E31CF55D00EEB027462 | Adult hyperkalemia bundleSource IDH51-29511568983B73AB2F20F86C | Commonly 5 to 10 units regular insulin with dextrose per protocolSource IDH51-DB4D56D567C6609FDA4DA3E2 | Commonly 5 to 10 units regular insulin with dextrose per protocolSource IDH51-B86CDAEB8ABC333FD06097F5 | Patient- and indication-specificSource IDH51-046FC436CF2BD3F23B923770 | See current package insertSource IDH51-26C530EC2AF97CE8D36BFA64 | IV bolus per hyperkalemia protocolSource IDH51-12C9AE46F42BDE483690719E | Existing GlobalRPh IV push snapshotSource IDH51-C6698E83BB3D9FDAC3D4225C | High-alert protocol only Hypoglycemia can occur several hours later; dextrose and monitoring plan are mandatory.Source IDH51-AA2A1715341365E3FBBBA0A7 |
Source IDH51-21BEEF996F4A2D3B2ABA524BSource IDH51-A2DCCF12EA7D9588B70D7DFB | AdultSource IDH51-F7459B95706A9961BA5B3CDB | Existing continuous-infusion recordSource IDH51-A438CA8D814186BB016B2055 | Indication-specific; DKA often 0.1 unit/kg/hour or protocol alternativeSource IDH51-F7B3C670199067E3AACC98A1 | Continuous infusion; titration-specificSource IDH51-F0EF2A49602AC8C84F84E671 | Clinical-response dependentSource IDH51-53F2915B984C53935B73E101 | Titrate to glucose, ketone, and anion-gap goalsSource IDH51-EAA54F7CE35933321F444EEF | Existing GlobalRPh continuous-infusion snapshotSource IDH51-0B19CC4773BDF57670C758D5 | Protocol-specific Use a dedicated line and standardized glucose/potassium monitoring.Source IDH51-0535F452AC5AA1AD69EFCDEB |
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- monitor_or_titrate
Source ID
H51-C2A2BAD2768E689DED2930D6 - Summary
- Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
Source ID
H51-192FA71402BFD7C52E519123 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-F4905D2531FE17C2FE6A0CC2
Historical Common IV uses
Recovered v5.1 source content; historical, awaiting current review.
- Diabetic ketoacidosis
Source ID
H51-BC5706CA82339664D0B95A5D - Hyperglycemia in critical illness
Source ID
H51-6D2B5139CF656A70BABBDC3F - Hyperkalemia as part of a treatment bundle
Source ID
H51-B324CA44233667AD0B00B75E
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Hypoglycemia and hypokalemia.
Source ID
H51-32BEA36774A4DD8F12B064DB - Tenfold concentration errors can be fatal.
Source ID
H51-085ECC1E43D020B707BC71AF - Only regular insulin is routinely used IV unless a specific product/protocol says otherwise.
Source ID
H51-4E1C0952A4C4A0BBD5C7A3E9
Historical Monitoring
Recovered v5.1 source content; historical, awaiting current review.
- Point-of-care glucose at protocol intervals
Source ID
H51-6E30EE6C44A09D204A4B4D4B - Potassium and metabolic parameters
Source ID
H51-7DD15B9CFC7212DCFABFA068 - Nutrition changes and interruptions
Source ID
H51-A5CDFBCED832F89013BFA47E
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
regular-insulinSource ID
H51-B84C222C904E37257B73EC17Generic name
Regular insulinSource ID
H51-3D168B31BD934548559EBCDEBrand names
- Humulin R
Source ID
H51-C317631755D21E81F4582853 - Novolin R
Source ID
H51-810872B2358FDCC9C8C5E769
Aliases
- insulin infusion
Source ID
H51-C893676B444A7D196ECA9CE2
Class
Endocrine and metabolicSource ID
H51-B60AEEA0D6BD244982026A56Subclass
Short-acting insulinSource ID
H51-DDF096019E43C31B40462B9ESummary
High-alert medication administered by standardized IV infusion for indication-specific protocols; adsorption to tubing may require priming.Source ID
H51-DA347F91BCF71B39F6F7865APopulations
- Adult
Source ID
H51-99D1AEF8B81FAC6891F7BFEE - Pediatric
Source ID
H51-28DD3A4BDFA794B64AC95151
Evidence tier
Core reference - verify current labelSource ID
H51-2B87FDF8852763FDC73DDD13High alert
trueSource ID
H51-BBB3CD18F9B6036574910486Hazardous
falseSource ID
H51-736014E34929E59B0E796826Status
ActiveSource ID
H51-7413E4961F07249DC467561CReviewed
2026-08-29Source ID
H51-CB4AE7EAADEEDC12C9EFDE3CVersion added
1.0Source ID
H51-105B038D52A5CFA56CBF8C47Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-0545D72E431C64E971A6A0D7Source IDH51-C55B4035C1C18F3B041C3FBF | https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Regular+insulin (opens in a new tab)Source IDH51-578DA5359F046E666761868E | PrimarySource IDH51-86C5FFACA516E9B81DEC5270 |
Source IDH51-AB7D5F632D6B9D94C5637AD5Source IDH51-540F66251AE209C63C794F55 | legacy:autoSource IDH51-17AA1FF4F17F6CBC61661BCD | LegacySource IDH51-493B93323C87F26E75E24833 |
Legacy title
Regular insulinSource ID
H51-BAF2653ACFFFE3E794B228B6Clinical release verification
- Audit version
- 3.4
Source ID
H51-146A3FE506DE75F2598C07ED - Audited on
- 2026-08-30
Source ID
H51-EB44B35F2729376CAF361707 - Level
- amber
Source ID
H51-B04243917B1BCCA4EFBD2632 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-58863893523EEA29CE6CA73F - Exact current label candidate
- false
Source ID
H51-99D0C5D86C52E72618C2809E - Numeric support ratio
- 0
Source ID
H51-C51CC1309C386DB003D97E6C - Reference url count
- 1
Source ID
H51-9567188330475559646F6CC7 - Broken reference count
- 0
Source ID
H51-50860821E191511BA930A774 - Point of use confirmation required
- true
Source ID
H51-044D7BA302DCC341FA72B6AA - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-C4D60B55CB6472C8891DEA66 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Regular%20insulin (opens in a new tab)
Source ID
H51-F17CBFC45339B4148762FB20
Dosing source fields
Id
regular-insulinSource ID
H51-5E436D27668BEFC561082586Generic name
Regular insulinSource ID
H51-4FA009E075E67D4CD080CFE0Coverage status
direct_official_label_access_plus_local_snapshotSource ID
H51-BFA7C696F428CE3A5E7085AEPackage insert
- Query name
- Regular insulin
Source ID
H51-9020DF1AFB0AAE02A97F6670 - Product and route must match
- true
Source ID
H51-8F159E04B23B7FB986633F0A - Live current label enabled
- false
Source ID
H51-7D8D5FF91F93A4134642CCA6 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-DFC428B1AD1A93B5C51EF2A9 - Direct official label access enabled
- true
Source ID
H51-5C46B08CF7E0558C4D79216B - Outbound server request required
- false
Source ID
H51-8E8B7936C2A7EF4F9A6BC2C4 - Local summary status
- not_bundled
Source ID
H51-94584DE3133E222B4090B639
Clinical review
- Locally normalized
- false
Source ID
H51-0B9D54AE4CB919F32DFF8246 - Reviewed
- 2026-08-29
Source ID
H51-A6015D666D8E8A45CB376737 - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-0EFC6B70E24F3CC5843BE3AF
Clinical release verification
- Audit version
- 3.4
Source ID
H51-FDF41AB8DB3A9F62EF49CEA3 - Audited on
- 2026-08-30
Source ID
H51-3F5C69854F8F46BF0317F73D - Level
- amber
Source ID
H51-E77412D7015B15DA63CC9AAE - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-DC64E7FE2F22DBC013ECF8A0 - Exact current label candidate
- false
Source ID
H51-1CF3F1B2E38E558A0743EAFE - Numeric support ratio
- 0
Source ID
H51-4F859FE76B20B978DFAE88E0 - Reference url count
- 1
Source ID
H51-FAED69FC756B6A03824B8E05 - Broken reference count
- 0
Source ID
H51-36F74629E55008391192C161 - Point of use confirmation required
- true
Source ID
H51-4736F24861A817B5CE1C8247 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-08A4F881CDFBEEFFD2354664 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Regular%20insulin (opens in a new tab)
Source ID
H51-BF9E0B20B82A6A61F205D5DD
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- regular-insulin
Source ID
H51-154F5897CF80083FA671CC5D - Name
- Regular insulin
Source ID
H51-3C420496170E3916CF7A2CAD - Brands
- Humulin R | Novolin R
Source ID
H51-C38236A1C6FA2E56E86CA694 - Therapeutic class
- Endocrine and metabolic
Source ID
H51-CDFEF88443A14DC267FECF56 - Review version
- 3.1
Source ID
H51-1CA5C1D699EE3CC100BEB0DA - Review date
- 2026-08-30
Source ID
H51-9C9F0A393F2F6DE0DE6DBC6E - Release status
- structured_record_current_label_not_confirmed
Source ID
H51-E3CDFD7A73F45BF72264AEF4 - Market status
- Status
- no_current_us_iv_spl_confirmed
Source ID
H51-8125CADB79B5C298362C7B2A - Basis
- No high-confidence current IV SPL was automatically selected; legacy information is segregated
Source ID
H51-E4F3B70836CBE584D2461FCA
- Ten point assessment
- Exact formulation
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-F0141FFD9EEBF19C1B20355E - Reconstitution concentration
- Add regular insulin to compatible bag using independent double check. Pharmacy-prepared standardized concentration.
Source ID
H51-B06AA976A104560DDE8B3580 - Maximum or recommended final concentration
- 100 units/100 mL NS (1 unit/mL)
Source ID
H51-A9E85BF8C37DAD6DB58B291F - Appropriate standardized containers
- 100 mL Weight-appropriate volume
Source ID
H51-18FEF30FEA811FCE537E6AB9 - Adult dosing range
- Common bag 100 units Weight-based protocol Commonly 5 to 10 units regular insulin with dextrose per protocol Indication-specific; DKA often 0.1 unit/kg/hour or protocol alternative Commonly 5 to 10 units regular insulin with dextrose per protocol
Source ID
H51-B23405F8D6C91FE2C2D574C5 - Pediatric dosing range
- DKA often 0.1 unit/kg/hour or protocol alternative | titration: Titrate to glucose, ketone, and anion-gap goals | maximum: Protocol-specific | notes: Use a dedicated line and standardized glucose/potassium monitoring. | warnings: Hypoglycemia and hypokalemia. | Tenfold concentration errors can be fatal. | Only regular insulin is routinely used IV unless a specific product/protocol says otherwise. | monitoring: Point-of-care glucose at protocol intervals | Potassium and metabolic parameters | Nutrition changes and interruptions | populations: Adult | Pediatric | evidence_tier: Core reference - verify current label | high_alert: true | hazardous: false | status: Active | reviewed: 2026-08-29 | version_added: 1.0 | sources: label: DailyMed label search | url: https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Regular+insulin | kind: Primary | label: GlobalRPh legacy IV dilution monograph | url: legacy:auto | kind: Legacy | legacy_title: Regular insulin
Source ID
H51-9D331F9B61BA2FC1E1D8093E - Neonatal dosing range
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-E5401B90F3CB2C3416A4C055 - Infusion time
- Titrate by units/hour or units/kg/hour according to protocol Titrate by units/kg/hour IV bolus per hyperkalemia protocol Indication-specific; DKA often 0.1 unit/kg/hour or protocol alternative
Source ID
H51-3B9C30D39DBAF23394DEE871 - Fluid restriction alternatives
- Not established in the currently normalized record. Use the current-label panel before clinical use.
Source ID
H51-79B73F083BEE8704C26AFA9B - Current manufacturer labeling
- Match confidence
- unresolved
Source ID
H51-E9B249486B5FEC93039F7D94 - Url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Regular+insulin (opens in a new tab)
Source ID
H51-AD85557C28F0BF1F8311F30E
- Field provenance
- Exact formulation
- Primary
- not_found
Source ID
H51-8ECF4326B4050B04C5822634
- Reconstitution concentration
- Primary
- existing_structured_record
Source ID
H51-901E01644C5D2B43B7150052
- Maximum or recommended final concentration
- Primary
- existing_structured_record
Source ID
H51-808532B59A948EB101E38BF6
- Appropriate standardized containers
- Primary
- existing_structured_record
Source ID
H51-4729F05CCCAA84E5A6AC64CB
- Adult dosing range
- Primary
- existing_structured_record
Source ID
H51-608CD4C7706247EFBFB021B9
- Pediatric dosing range
- Primary
- existing_record_text
Source ID
H51-A5F49FDA12E767E72D07CF86
- Neonatal dosing range
- Primary
- not_found
Source ID
H51-D7C3CB156B5CFBA42A2A0D8D
- Infusion time
- Primary
- existing_structured_record
Source ID
H51-71912A9E8B4138951A8C8634
- Fluid restriction alternatives
- Primary
- not_found
Source ID
H51-B8AA6E8B940FB7CDCBE2E5E2
- Current manufacturer labeling
- Primary
- DailyMed search gateway
Source ID
H51-495FC7F4D0A8ACEE3B39DC23
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-8A58D2F0CFDF9982B1F0A015 - Guide generation allowed
- true
Source ID
H51-847F375EE2B51A4C093CE8EB
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-FFAFA020C719FC1B779309B7 - Guide generation allowed
- false
Source ID
H51-50566F13447A3782487DD6B2
- Neonatal
- Applicability
- not_established
Source ID
H51-4C95DC7AB172C26FE128C740 - Guide generation allowed
- false
Source ID
H51-FC30784B28B10848E5FEDF89
- Route presence
- Structured dilution
- true
Source ID
H51-CDF0DB50D5A7C0C366334934 - Iv push
- true
Source ID
H51-214A4DD1AB823F2130931FBD - Continuous infusion
- true
Source ID
H51-A160F2E93D81B620338A69E7 - Pediatric source
- true
Source ID
H51-C422E2ACD004811DAE00EB8C - Neonatal source
- false
Source ID
H51-A30F81AF0A3494065D80EBE0
- Legacy reference
- Status
- not_available
Source ID
H51-37FA0CFF58FA158477E0A059
- Label resolution
- Status
- build_environment_network_unavailable
Source ID
H51-89892570B56D13811A0277B7
- Concentration values detected
High Unit Text 1Source ID
H51-49146995F67584B540C7BBB7Source ID
H51-600FEAFA88BB393ED0C1E1DAunit Source ID
H51-9F5DE4D763259BBC896B84B21 unit/mL Source ID
H51-6473E342F4846893E2B92679- Source files
- catalog.json
Source ID
H51-27DF773B4B8AB26BC0477C5B - dosing.json
Source ID
H51-2760441B884326A78438BDAD - legacy-map.json
Source ID
H51-3ADAFDADD1B26C1E52943CF7
- catalog.json
- Clinical release note
- Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
Source ID
H51-962EB6FB18D776011BA8CDAA
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-B84C222C904E37257B73EC17 | catalog.json/records/216/id | Historical; current review incomplete |
H51-3D168B31BD934548559EBCDE | catalog.json/records/216/generic_name | Historical; current review incomplete |
H51-C317631755D21E81F4582853 | catalog.json/records/216/brand_names/0 | Historical; current review incomplete |
H51-810872B2358FDCC9C8C5E769 | catalog.json/records/216/brand_names/1 | Historical; current review incomplete |
H51-C893676B444A7D196ECA9CE2 | catalog.json/records/216/aliases/0 | Historical; current review incomplete |
H51-B60AEEA0D6BD244982026A56 | catalog.json/records/216/class | Historical; current review incomplete |
H51-DDF096019E43C31B40462B9E | catalog.json/records/216/subclass | Historical; current review incomplete |
H51-DA347F91BCF71B39F6F7865A | catalog.json/records/216/summary | Historical; current review incomplete |
H51-BC5706CA82339664D0B95A5D | catalog.json/records/216/common_uses/0 | Historical; current review incomplete |
H51-6D2B5139CF656A70BABBDC3F | catalog.json/records/216/common_uses/1 | Historical; current review incomplete |
H51-B324CA44233667AD0B00B75E | catalog.json/records/216/common_uses/2 | Historical; current review incomplete |
H51-F3E273BB0E48CB9293CC964E | catalog.json/records/216/preparations/0 | Historical; current review incomplete |
H51-0FACCA26B5682EF73B51EADB | catalog.json/records/216/preparations/0/population | Historical; current review incomplete |
H51-F5B9D40DE739C83F51EFF9A9 | catalog.json/records/216/preparations/0/amount | Historical; current review incomplete |
H51-6F3034A456C019A90756B1F3 | catalog.json/records/216/preparations/0/reconstitution | Historical; current review incomplete |
H51-73AFAD5788BB6FB0816BC64A | catalog.json/records/216/preparations/0/diluent | Historical; current review incomplete |
H51-C883F472086513D392200348 | catalog.json/records/216/preparations/0/final_volume | Historical; current review incomplete |
H51-6989D752FF76B94BFC8C01F6 | catalog.json/records/216/preparations/0/concentration | Historical; current review incomplete |
H51-ED6A4C5A5D1810FBD56C23FF | catalog.json/records/216/preparations/0/rate | Historical; current review incomplete |
H51-4554F8C3A754A513C7E46E68 | catalog.json/records/216/preparations/0/stability | Historical; current review incomplete |
H51-20F6FC44E8240376BBD806AF | catalog.json/records/216/preparations/0/notes | Historical; current review incomplete |
H51-BC5D4A057D15BB5EA4CBE48A | catalog.json/records/216/preparations/1 | Historical; current review incomplete |
H51-5663BD58F110BCF31448BDDD | catalog.json/records/216/preparations/1/population | Historical; current review incomplete |
H51-17CCF9817ABDA92DA81B30FB | catalog.json/records/216/preparations/1/amount | Historical; current review incomplete |
H51-85E7F2146DC27384E6B2879C | catalog.json/records/216/preparations/1/reconstitution | Historical; current review incomplete |
H51-4CA579D6890B64B8C91F07BD | catalog.json/records/216/preparations/1/diluent | Historical; current review incomplete |
H51-09C1E838D979939151499ECF | catalog.json/records/216/preparations/1/final_volume | Historical; current review incomplete |
H51-207FC6CB56FD30FC85D93592 | catalog.json/records/216/preparations/1/concentration | Historical; current review incomplete |
H51-61B796B4593244BCEE0DED4F | catalog.json/records/216/preparations/1/rate | Historical; current review incomplete |
H51-B29D1C31531B8426C8DE7288 | catalog.json/records/216/preparations/1/stability | Historical; current review incomplete |
H51-EE31F647C30085FED94BE96C | catalog.json/records/216/preparations/1/notes | Historical; current review incomplete |
H51-17D811A90BC1A4955934B22C | catalog.json/records/216/iv_push/0 | Historical; current review incomplete |
H51-F0ECAD09B30F4BC050DCC07D | catalog.json/records/216/iv_push/0/population | Historical; current review incomplete |
H51-F6924C5E5086406522933F3F | catalog.json/records/216/iv_push/0/dose_scope | Historical; current review incomplete |
H51-D47F1D0B8829FFB65C0EE92F | catalog.json/records/216/iv_push/0/concentration | Historical; current review incomplete |
H51-5958F7254FDE3ED7C88CE135 | catalog.json/records/216/iv_push/0/rate | Historical; current review incomplete |
H51-CDE724012C78EA86704D3FA4 | catalog.json/records/216/iv_push/0/status | Historical; current review incomplete |
H51-0C9AA4501F9ADBAAC2E1CBB7 | catalog.json/records/216/iv_push/0/notes | Historical; current review incomplete |
H51-2728AAA8F1212E0424D241BB | catalog.json/records/216/continuous_infusions/0 | Historical; current review incomplete |
H51-4652432F6C874C4D5D399B75 | catalog.json/records/216/continuous_infusions/0/population | Historical; current review incomplete |
H51-C4A5E8E735CC53F8809CDD5D | catalog.json/records/216/continuous_infusions/0/standard_concentration | Historical; current review incomplete |
H51-24DA306C3FC1329449F23E7F | catalog.json/records/216/continuous_infusions/0/initial_rate | Historical; current review incomplete |
H51-3411EC538DF25A44D1D4B904 | catalog.json/records/216/continuous_infusions/0/titration | Historical; current review incomplete |
H51-EAB99F7A6AC9540D8319BED5 | catalog.json/records/216/continuous_infusions/0/maximum | Historical; current review incomplete |
H51-8BBF9351223C3FEB04B3ADB3 | catalog.json/records/216/continuous_infusions/0/notes | Historical; current review incomplete |
H51-32BEA36774A4DD8F12B064DB | catalog.json/records/216/warnings/0 | Historical; current review incomplete |
H51-085ECC1E43D020B707BC71AF | catalog.json/records/216/warnings/1 | Historical; current review incomplete |
H51-4E1C0952A4C4A0BBD5C7A3E9 | catalog.json/records/216/warnings/2 | Historical; current review incomplete |
H51-6E30EE6C44A09D204A4B4D4B | catalog.json/records/216/monitoring/0 | Historical; current review incomplete |
H51-7DD15B9CFC7212DCFABFA068 | catalog.json/records/216/monitoring/1 | Historical; current review incomplete |
H51-A5CDFBCED832F89013BFA47E | catalog.json/records/216/monitoring/2 | Historical; current review incomplete |
H51-99D1AEF8B81FAC6891F7BFEE | catalog.json/records/216/populations/0 | Historical; current review incomplete |
H51-28DD3A4BDFA794B64AC95151 | catalog.json/records/216/populations/1 | Historical; current review incomplete |
H51-2B87FDF8852763FDC73DDD13 | catalog.json/records/216/evidence_tier | Historical; current review incomplete |
H51-BBB3CD18F9B6036574910486 | catalog.json/records/216/high_alert | Historical; current review incomplete |
H51-736014E34929E59B0E796826 | catalog.json/records/216/hazardous | Historical; current review incomplete |
H51-7413E4961F07249DC467561C | catalog.json/records/216/status | Historical; current review incomplete |
H51-CB4AE7EAADEEDC12C9EFDE3C | catalog.json/records/216/reviewed | Historical; current review incomplete |
H51-105B038D52A5CFA56CBF8C47 | catalog.json/records/216/version_added | Historical; current review incomplete |
H51-0545D72E431C64E971A6A0D7 | catalog.json/records/216/sources/0 | Historical; current review incomplete |
H51-C55B4035C1C18F3B041C3FBF | catalog.json/records/216/sources/0/label | Historical; current review incomplete |
H51-578DA5359F046E666761868E | catalog.json/records/216/sources/0/url | Historical; current review incomplete |
H51-86C5FFACA516E9B81DEC5270 | catalog.json/records/216/sources/0/kind | Historical; current review incomplete |
H51-AB7D5F632D6B9D94C5637AD5 | catalog.json/records/216/sources/1 | Historical; current review incomplete |
H51-540F66251AE209C63C794F55 | catalog.json/records/216/sources/1/label | Historical; current review incomplete |
H51-17AA1FF4F17F6CBC61661BCD | catalog.json/records/216/sources/1/url | Historical; current review incomplete |
H51-493B93323C87F26E75E24833 | catalog.json/records/216/sources/1/kind | Historical; current review incomplete |
H51-BAF2653ACFFFE3E794B228B6 | catalog.json/records/216/legacy_title | Historical; current review incomplete |
H51-146A3FE506DE75F2598C07ED | catalog.json/records/216/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-EB44B35F2729376CAF361707 | catalog.json/records/216/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-B04243917B1BCCA4EFBD2632 | catalog.json/records/216/clinical_release_verification/level | Historical; current review incomplete |
H51-58863893523EEA29CE6CA73F | catalog.json/records/216/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-99D0C5D86C52E72618C2809E | catalog.json/records/216/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-6FD790957EA8B3B14AE3D0D3 | catalog.json/records/216/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-405CD5DC2A0B83F709ADCFEC | catalog.json/records/216/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-C51CC1309C386DB003D97E6C | catalog.json/records/216/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-9567188330475559646F6CC7 | catalog.json/records/216/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-50860821E191511BA930A774 | catalog.json/records/216/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-044D7BA302DCC341FA72B6AA | catalog.json/records/216/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-C4D60B55CB6472C8891DEA66 | catalog.json/records/216/clinical_release_verification/note | Historical; current review incomplete |
H51-F17CBFC45339B4148762FB20 | catalog.json/records/216/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-5E436D27668BEFC561082586 | dosing.json/records/216/id | Historical; current review incomplete |
H51-4FA009E075E67D4CD080CFE0 | dosing.json/records/216/generic_name | Historical; current review incomplete |
H51-BFA7C696F428CE3A5E7085AE | dosing.json/records/216/coverage_status | Historical; current review incomplete |
H51-9020DF1AFB0AAE02A97F6670 | dosing.json/records/216/package_insert/query_name | Historical; current review incomplete |
H51-9FDB8A7AC6666341B2D98A6E | dosing.json/records/216/package_insert/preferred_setid | Historical; current review incomplete |
H51-8F159E04B23B7FB986633F0A | dosing.json/records/216/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-7D8D5FF91F93A4134642CCA6 | dosing.json/records/216/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-DFC428B1AD1A93B5C51EF2A9 | dosing.json/records/216/package_insert/source_priority | Historical; current review incomplete |
H51-5C46B08CF7E0558C4D79216B | dosing.json/records/216/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-8E8B7936C2A7EF4F9A6BC2C4 | dosing.json/records/216/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-94584DE3133E222B4090B639 | dosing.json/records/216/package_insert/local_summary_status | Historical; current review incomplete |
H51-C2A2BAD2768E689DED2930D6 | dosing.json/records/216/renal/classification | Historical; current review incomplete |
H51-192FA71402BFD7C52E519123 | dosing.json/records/216/renal/summary | Historical; current review incomplete |
H51-F4905D2531FE17C2FE6A0CC2 | dosing.json/records/216/renal/method_note | Historical; current review incomplete |
H51-7362A06452A1F8245FFD52EA | dosing.json/records/216/existing_route_snapshots/0 | Historical; current review incomplete |
H51-7289AAFE716ADC06B35A1812 | dosing.json/records/216/existing_route_snapshots/0/route | Historical; current review incomplete |
H51-A98183C6A0CD5CDC5F29C97E | dosing.json/records/216/existing_route_snapshots/0/population | Historical; current review incomplete |
H51-EAC690941F373CCCEA744AFC | dosing.json/records/216/existing_route_snapshots/0/indication | Historical; current review incomplete |
H51-8369F0831362D17396CBF38A | dosing.json/records/216/existing_route_snapshots/0/dose | Historical; current review incomplete |
H51-421FCF7C5D706126CEF6FBB9 | dosing.json/records/216/existing_route_snapshots/0/interval | Historical; current review incomplete |
H51-D50F2BBC4442FDBA914AB5AA | dosing.json/records/216/existing_route_snapshots/0/duration | Historical; current review incomplete |
H51-D5AA4A7231CF86F174DCE77C | dosing.json/records/216/existing_route_snapshots/0/administration | Historical; current review incomplete |
H51-C84B3602ED0696918B1A19D7 | dosing.json/records/216/existing_route_snapshots/0/source_level | Historical; current review incomplete |
H51-1AFAA3101DB42E4BF1CC7F80 | dosing.json/records/216/existing_route_snapshots/0/notes | Historical; current review incomplete |
H51-2CC4B8D6BB6CDCDA4BEECA2A | dosing.json/records/216/existing_route_snapshots/1 | Historical; current review incomplete |
H51-805626FBAE368D50E445D236 | dosing.json/records/216/existing_route_snapshots/1/route | Historical; current review incomplete |
H51-063F0301FF7AF28FC9B4B121 | dosing.json/records/216/existing_route_snapshots/1/population | Historical; current review incomplete |
H51-F781A823A182AA128B2FC225 | dosing.json/records/216/existing_route_snapshots/1/indication | Historical; current review incomplete |
H51-D2A9EA5A8A3D25AB42D24C04 | dosing.json/records/216/existing_route_snapshots/1/dose | Historical; current review incomplete |
H51-7DA55DFD6626EE1F05935987 | dosing.json/records/216/existing_route_snapshots/1/interval | Historical; current review incomplete |
H51-165535F13B067E8C7D853B46 | dosing.json/records/216/existing_route_snapshots/1/duration | Historical; current review incomplete |
H51-09A56030125531A303972FDC | dosing.json/records/216/existing_route_snapshots/1/administration | Historical; current review incomplete |
H51-2BB273A7ECBD15CD7DFCA2F8 | dosing.json/records/216/existing_route_snapshots/1/source_level | Historical; current review incomplete |
H51-599E3BAB257A9FCC9E994D06 | dosing.json/records/216/existing_route_snapshots/1/notes | Historical; current review incomplete |
H51-3CA35283BAF521CFEC7309AE | dosing.json/records/216/existing_route_snapshots/2 | Historical; current review incomplete |
H51-F0A02E31CF55D00EEB027462 | dosing.json/records/216/existing_route_snapshots/2/route | Historical; current review incomplete |
H51-29511568983B73AB2F20F86C | dosing.json/records/216/existing_route_snapshots/2/population | Historical; current review incomplete |
H51-DB4D56D567C6609FDA4DA3E2 | dosing.json/records/216/existing_route_snapshots/2/indication | Historical; current review incomplete |
H51-B86CDAEB8ABC333FD06097F5 | dosing.json/records/216/existing_route_snapshots/2/dose | Historical; current review incomplete |
H51-046FC436CF2BD3F23B923770 | dosing.json/records/216/existing_route_snapshots/2/interval | Historical; current review incomplete |
H51-26C530EC2AF97CE8D36BFA64 | dosing.json/records/216/existing_route_snapshots/2/duration | Historical; current review incomplete |
H51-12C9AE46F42BDE483690719E | dosing.json/records/216/existing_route_snapshots/2/administration | Historical; current review incomplete |
H51-C6698E83BB3D9FDAC3D4225C | dosing.json/records/216/existing_route_snapshots/2/source_level | Historical; current review incomplete |
H51-AA2A1715341365E3FBBBA0A7 | dosing.json/records/216/existing_route_snapshots/2/notes | Historical; current review incomplete |
H51-21BEEF996F4A2D3B2ABA524B | dosing.json/records/216/existing_route_snapshots/3 | Historical; current review incomplete |
H51-A2DCCF12EA7D9588B70D7DFB | dosing.json/records/216/existing_route_snapshots/3/route | Historical; current review incomplete |
H51-F7459B95706A9961BA5B3CDB | dosing.json/records/216/existing_route_snapshots/3/population | Historical; current review incomplete |
H51-A438CA8D814186BB016B2055 | dosing.json/records/216/existing_route_snapshots/3/indication | Historical; current review incomplete |
H51-F7B3C670199067E3AACC98A1 | dosing.json/records/216/existing_route_snapshots/3/dose | Historical; current review incomplete |
H51-F0EF2A49602AC8C84F84E671 | dosing.json/records/216/existing_route_snapshots/3/interval | Historical; current review incomplete |
H51-53F2915B984C53935B73E101 | dosing.json/records/216/existing_route_snapshots/3/duration | Historical; current review incomplete |
H51-EAA54F7CE35933321F444EEF | dosing.json/records/216/existing_route_snapshots/3/administration | Historical; current review incomplete |
H51-0B19CC4773BDF57670C758D5 | dosing.json/records/216/existing_route_snapshots/3/source_level | Historical; current review incomplete |
H51-0535F452AC5AA1AD69EFCDEB | dosing.json/records/216/existing_route_snapshots/3/notes | Historical; current review incomplete |
H51-0B9D54AE4CB919F32DFF8246 | dosing.json/records/216/clinical_review/locally_normalized | Historical; current review incomplete |
H51-A6015D666D8E8A45CB376737 | dosing.json/records/216/clinical_review/reviewed | Historical; current review incomplete |
H51-0EFC6B70E24F3CC5843BE3AF | dosing.json/records/216/clinical_review/status | Historical; current review incomplete |
H51-FDF41AB8DB3A9F62EF49CEA3 | dosing.json/records/216/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-3F5C69854F8F46BF0317F73D | dosing.json/records/216/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-E77412D7015B15DA63CC9AAE | dosing.json/records/216/clinical_release_verification/level | Historical; current review incomplete |
H51-DC64E7FE2F22DBC013ECF8A0 | dosing.json/records/216/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-1CF3F1B2E38E558A0743EAFE | dosing.json/records/216/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-C3B27B5BE953FA9B8271FA68 | dosing.json/records/216/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-63AF8B8CDEB796FAF0DC3D25 | dosing.json/records/216/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-4F859FE76B20B978DFAE88E0 | dosing.json/records/216/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-FAED69FC756B6A03824B8E05 | dosing.json/records/216/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-36F74629E55008391192C161 | dosing.json/records/216/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-4736F24861A817B5CE1C8247 | dosing.json/records/216/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-08A4F881CDFBEEFFD2354664 | dosing.json/records/216/clinical_release_verification/note | Historical; current review incomplete |
H51-BF9E0B20B82A6A61F205D5DD | dosing.json/records/216/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-90A97AEDD80AF98A0A6ED6CE | first-look-v5.1.json/records/216/id | Historical; current review incomplete |
H51-DF4F0CACF316F9700DE7CEAB | first-look-v5.1.json/records/216/generic_name | Historical; current review incomplete |
H51-FDC87B51CA7EEDD613C36F92 | first-look-v5.1.json/records/216/class | Historical; current review incomplete |
H51-A630F15112EAF7EF14B4A656 | first-look-v5.1.json/records/216/subclass | Historical; current review incomplete |
H51-07D10EB6108309113410599B | first-look-v5.1.json/records/216/primary_uses/0 | Historical; current review incomplete |
H51-4A913D16229C57EBDF1FE3BA | first-look-v5.1.json/records/216/primary_uses/1 | Historical; current review incomplete |
H51-B2E943B4070D5AA083FFAA23 | first-look-v5.1.json/records/216/primary_uses/2 | Historical; current review incomplete |
H51-A754E15EAA24FF56F6AA569F | first-look-v5.1.json/records/216/mechanism | Historical; current review incomplete |
H51-38EB1DFFD6A14A60E70FEB9F | first-look-v5.1.json/records/216/mechanism_level | Historical; current review incomplete |
H51-A41BA7345B1DFBDCA3CECE4D | first-look-v5.1.json/records/216/basic_dosing_orientation | Historical; current review incomplete |
H51-49A33171559FDA755405B50F | first-look-v5.1.json/records/216/administration_orientation | Historical; current review incomplete |
H51-32172B699DD63A267988E8E8 | first-look-v5.1.json/records/216/renal_and_population_orientation | Historical; current review incomplete |
H51-8FF16E0D7F4459BFFA948010 | first-look-v5.1.json/records/216/key_safety_orientation/0 | Historical; current review incomplete |
H51-41C6376ED41AC383F5884361 | first-look-v5.1.json/records/216/key_safety_orientation/1 | Historical; current review incomplete |
H51-A21934504DE408F785BE5E22 | first-look-v5.1.json/records/216/key_safety_orientation/2 | Historical; current review incomplete |
H51-06C4DDBAF45DDAA500D537CD | first-look-v5.1.json/records/216/coverage_path | Historical; current review incomplete |
H51-1DC669C50CABC7CFC4E61674 | first-look-v5.1.json/records/216/coverage_path_label | Historical; current review incomplete |
H51-BA20A16D19D072718C359205 | first-look-v5.1.json/records/216/official_label_url | Historical; current review incomplete |
H51-19C995EC70FD0B010384281E | first-look-v5.1.json/records/216/legacy_title | Historical; current review incomplete |
H51-BEB63915E2B2AF98140C1667 | first-look-v5.1.json/records/216/review_note | Historical; current review incomplete |
H51-49D559980EBE24404E1377FF | first-look-v5.1.json/records/216/search_text | Historical; current review incomplete |
H51-E30C7D67980B93BEE59B0115 | first-look-v5.1.json/records/216/official_search_url | Historical; current review incomplete |
H51-0ABC8EF048E33A3CBE6D6249 | first-look-v5.1.json/records/216/official_access_mode | Historical; current review incomplete |
H51-B6E2F46A049D87946616E026 | first-look-v5.1.json/records/216/official_access_url | Historical; current review incomplete |
H51-F673A314EAD15F87C53850FD | first-look-v5.1.json/records/216/official_search_query | Historical; current review incomplete |
H51-081289169F76DEF84A01A630 | first-look-v5.1.json/records/216/official_access_reason | Historical; current review incomplete |
H51-154F5897CF80083FA671CC5D | preparation-assessments-v3.8.json/216/id | Historical; current review incomplete |
H51-3C420496170E3916CF7A2CAD | preparation-assessments-v3.8.json/216/name | Historical; current review incomplete |
H51-C38236A1C6FA2E56E86CA694 | preparation-assessments-v3.8.json/216/brands | Historical; current review incomplete |
H51-CDFEF88443A14DC267FECF56 | preparation-assessments-v3.8.json/216/therapeutic_class | Historical; current review incomplete |
H51-1CA5C1D699EE3CC100BEB0DA | preparation-assessments-v3.8.json/216/review_version | Historical; current review incomplete |
H51-9C9F0A393F2F6DE0DE6DBC6E | preparation-assessments-v3.8.json/216/review_date | Historical; current review incomplete |
H51-E3CDFD7A73F45BF72264AEF4 | preparation-assessments-v3.8.json/216/release_status | Historical; current review incomplete |
H51-8125CADB79B5C298362C7B2A | preparation-assessments-v3.8.json/216/market_status/status | Historical; current review incomplete |
H51-E4F3B70836CBE584D2461FCA | preparation-assessments-v3.8.json/216/market_status/basis | Historical; current review incomplete |
H51-F0141FFD9EEBF19C1B20355E | preparation-assessments-v3.8.json/216/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-B06AA976A104560DDE8B3580 | preparation-assessments-v3.8.json/216/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-A9E85BF8C37DAD6DB58B291F | preparation-assessments-v3.8.json/216/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-18FEF30FEA811FCE537E6AB9 | preparation-assessments-v3.8.json/216/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-B23405F8D6C91FE2C2D574C5 | preparation-assessments-v3.8.json/216/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-9D331F9B61BA2FC1E1D8093E | preparation-assessments-v3.8.json/216/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-E5401B90F3CB2C3416A4C055 | preparation-assessments-v3.8.json/216/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-3B9C30D39DBAF23394DEE871 | preparation-assessments-v3.8.json/216/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-79B73F083BEE8704C26AFA9B | preparation-assessments-v3.8.json/216/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-CA3F4A8E148C5B8C0090805F | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-8FC2B8791EFA556F0FB3D689 | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-36BFE4AE9BA7C74FB9AD2B3A | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-4B255FC6308626C6208829CC | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-E9B249486B5FEC93039F7D94 | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-AD85557C28F0BF1F8311F30E | preparation-assessments-v3.8.json/216/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-8ECF4326B4050B04C5822634 | preparation-assessments-v3.8.json/216/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-901E01644C5D2B43B7150052 | preparation-assessments-v3.8.json/216/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-808532B59A948EB101E38BF6 | preparation-assessments-v3.8.json/216/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-4729F05CCCAA84E5A6AC64CB | preparation-assessments-v3.8.json/216/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-608CD4C7706247EFBFB021B9 | preparation-assessments-v3.8.json/216/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-A5F49FDA12E767E72D07CF86 | preparation-assessments-v3.8.json/216/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-D7C3CB156B5CFBA42A2A0D8D | preparation-assessments-v3.8.json/216/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-71912A9E8B4138951A8C8634 | preparation-assessments-v3.8.json/216/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-B8AA6E8B940FB7CDCBE2E5E2 | preparation-assessments-v3.8.json/216/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-495FC7F4D0A8ACEE3B39DC23 | preparation-assessments-v3.8.json/216/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-8A58D2F0CFDF9982B1F0A015 | preparation-assessments-v3.8.json/216/population_applicability/adult/applicability | Historical; current review incomplete |
H51-847F375EE2B51A4C093CE8EB | preparation-assessments-v3.8.json/216/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-FFAFA020C719FC1B779309B7 | preparation-assessments-v3.8.json/216/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-50566F13447A3782487DD6B2 | preparation-assessments-v3.8.json/216/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-4C95DC7AB172C26FE128C740 | preparation-assessments-v3.8.json/216/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-FC30784B28B10848E5FEDF89 | preparation-assessments-v3.8.json/216/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-CDF0DB50D5A7C0C366334934 | preparation-assessments-v3.8.json/216/route_presence/structured_dilution | Historical; current review incomplete |
H51-214A4DD1AB823F2130931FBD | preparation-assessments-v3.8.json/216/route_presence/iv_push | Historical; current review incomplete |
H51-A160F2E93D81B620338A69E7 | preparation-assessments-v3.8.json/216/route_presence/continuous_infusion | Historical; current review incomplete |
H51-C422E2ACD004811DAE00EB8C | preparation-assessments-v3.8.json/216/route_presence/pediatric_source | Historical; current review incomplete |
H51-A30F81AF0A3494065D80EBE0 | preparation-assessments-v3.8.json/216/route_presence/neonatal_source | Historical; current review incomplete |
H51-37FA0CFF58FA158477E0A059 | preparation-assessments-v3.8.json/216/legacy_reference/status | Historical; current review incomplete |
H51-89892570B56D13811A0277B7 | preparation-assessments-v3.8.json/216/label_resolution/status | Historical; current review incomplete |
H51-49146995F67584B540C7BBB7 | preparation-assessments-v3.8.json/216/concentration_values_detected/0 | Historical; current review incomplete |
H51-111F5E6A1F883B5D828BAA84 | preparation-assessments-v3.8.json/216/concentration_values_detected/0/low | Historical; current review incomplete |
H51-600FEAFA88BB393ED0C1E1DA | preparation-assessments-v3.8.json/216/concentration_values_detected/0/high | Historical; current review incomplete |
H51-9F5DE4D763259BBC896B84B2 | preparation-assessments-v3.8.json/216/concentration_values_detected/0/unit | Historical; current review incomplete |
H51-6473E342F4846893E2B92679 | preparation-assessments-v3.8.json/216/concentration_values_detected/0/text | Historical; current review incomplete |
H51-27DF773B4B8AB26BC0477C5B | preparation-assessments-v3.8.json/216/source_files/0 | Historical; current review incomplete |
H51-2760441B884326A78438BDAD | preparation-assessments-v3.8.json/216/source_files/1 | Historical; current review incomplete |
H51-3ADAFDADD1B26C1E52943CF7 | preparation-assessments-v3.8.json/216/source_files/2 | Historical; current review incomplete |
H51-962EB6FB18D776011BA8CDAA | preparation-assessments-v3.8.json/216/clinical_release_note | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)